UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Patient preferences for osteoporosis in Spain: a discrete choice experiment

Osteoporosis international, 2011-06, Vol.22 (6), p.1947-1954

2011

Volltextzugriff (PDF)

PCV72 Cost-Effectiveness of Rivaroxaban Versus Acenocumarol in the Stroke Prevention in Patients With Non-Valvular Atrial Fibrilation in the Spanish Setting

Value in health, 2012-11, Vol.15 (7), p.A375-A375

2012

Volltextzugriff (PDF)

Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours

Clinical & translational oncology, 2014-03, Vol.16 (3), p.322-329

2014

Volltextzugriff (PDF)

PCV109 Antithrombotic Therapy Prescription and Persistence in Patients With Atrial Fibrillation in France and Spain

Value in health, 2012-11, Vol.15 (7), p.A382-A382

2012

Volltextzugriff (PDF)

PCN33 Cost Analysis: Treatment of Chemotherapy-Induced Anaemia with Erythropoiesis-Stimulating Agents (ESAs) in Spain

Value in health, 2011, Vol.14 (7), p.A439-A439

2011

Volltextzugriff (PDF)

PMS68 - Biological Agents for Patients With Rheumatoid Arthritis Who Had Failed Treatment With Methotrexate In The Spanish Clinical Setting: A Cost-Effectiveness Analysis

Value in health, 2015-11, Vol.18 (7), p.A645-A646

2015

Volltextzugriff (PDF)

Biological Agents for Patients With Rheumatoid Arthritis Who Had Failed Treatment With Methotrexate In The Spanish Clinical Setting: A Cost-Effectiveness Analysis

Value in health, 2015-11, Vol.18 (7), p.A645-A646

2015

Volltextzugriff (PDF)

A simulation model to estimate the coronary heart disease risk in schizophrenic patients treated with second-generation-antipsychotic drugs: A Spanish perspective

European psychiatry, 2008-04, Vol.23, p.S139

2008

Volltextzugriff (PDF)

PHP216 - HOW RESPONSIVE IS INDUSTRY TO VALUE BASED PROCUREMENT (VBP)?

Value in health, 2018-10, Vol.21, p.S186-S186

2018

Volltextzugriff (PDF)

PCV89 - A Comparison Of Two Low-Molecular-Weight Heparins (Lmwhs) In Terms Of Cost Per Patient

Value in health, 2015-11, Vol.18 (7), p.A389-A389

2015

Volltextzugriff (PDF)

PCV63 - An Assesment Of Enoxaparine Benefit On Healthcare Budget In Spain

Value in health, 2015-11, Vol.18 (7), p.A384-A384

2015

Volltextzugriff (PDF)

A Comparison Of Two Low-Molecular-Weight Heparins (Lmwhs) In Terms Of Cost Per Patient

Value in health, 2015-11, Vol.18 (7), p.A389-A389

2015

Volltextzugriff (PDF)

An Assesment Of Enoxaparine Benefit On Healthcare Budget In Spain

Value in health, 2015-11, Vol.18 (7), p.A384-A384

2015

Volltextzugriff (PDF)

P913Optimization of cardiac resynchronization therapy device selection guided by cardiac magnetic resonance imaging is cost-effective

Europace (London, England), 2018-03, Vol.20 (suppl_1), p.i176-i176

2018

Volltextzugriff (PDF)

PIN10 A BUDGET IMPACT MODEL TO ESTIMATE THE ECONOMIC IMPACT OF ITRACONAZOLE IN PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH NEUTROPENIA IN SPAIN

Value in health, 2009, Vol.12 (7), p.A419-A419

2009

Volltextzugriff (PDF)

PIN64 A PROBABILISTIC COST-EFFECTIVENESS MODEL FOR PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH NEUTROPENIA IN SPAIN

Value in health, 2009, Vol.12 (7), p.A429-A429

2009

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain

Value in health, 2015-11, Vol.18 (7), p.A755-A755

2015

Volltextzugriff (PDF)

PND41 - Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain

Value in health, 2015-11, Vol.18 (7), p.A755-A755

2015

Volltextzugriff (PDF)

Posicionamiento de pegfilgrastim en las tablas clasificatorias de España según coste por años de vida ajustados por calidad (AVAC) y coste por años de vida ganados (AVG)

PharmacoEconomics. Spanish research articles, 2008, Vol.5 (3), p.94-107

2008

Volltextzugriff (PDF)

PG120 ASSESSING THE COST AND EFFECTIVENESS OF TERLIPRESSIN COMPARED WITH SOMATOSTATIN FOR THE TREATMENT OF BLEEDING OESOPHAGEAL VARICES IN SPAIN

Value in health, 2008, Vol.11 (6), p.A524-A524

2008

Volltextzugriff (PDF)

PG15 A BUDGET IMPACT ANALYSIS FOR DETERMINING THE COSTS OF INCREASED PANTOPRAZOL IV PRESCRIPTION FOR THE MANAGEMENT OF PEPTIC ULCER IN SPAIN

Value in health, 2008, Vol.11 (6), p.A519-A519

2008

Volltextzugriff (PDF)

PRS7 THE TREATMENT OF MODERATE TO SEVERE PERSISTENT ASTHMA IN SELECTED AUTONOMOUS COMMUNITIES IN SPAIN: AN ECOMIC MODELTO ESTIMATE BUDGET IMPACT CONSEQUENCES OF INTRODUCING BECLOMETHASONE/FORMOTEROL

Value in health, 2008, Vol.11 (6), p.A448-A448

2008

Volltextzugriff (PDF)

PG16 THE MANAGEMENT OF GASTRO OESOPHAGEAL REFLUX DISEASE IN SPAIN: A BUDGET IMPACT ANALYSIS TO ESTIMATE COSTS DUETO A GREATER PANTOPRAZOL IV PENETRATION

Value in health, 2008, Vol.11 (6), p.A519-A519

2008

Volltextzugriff (PDF)

PIN20 COST EFFECTIVENESS ANALYSIS OF BRIVUDINE COMPARED WITH ACICLOVIR FORTHETREATMENT OF HERPES ZOSTER IN SPAIN

Value in health, 2007, Vol.10 (6), p.A441-A442

2007

Volltextzugriff (PDF)

PAA3 A BUDGET IMPACT MODEL FOR DETERMINING THE COSTS OF INTRODUCING A NEW EXTRAFINE COMBINATION (BECLOMETHASONE/FORMOTEROL) FOR THE TREATMENT OF MODERATE TO SEVERE PERSISTENT ASTHMA IN SPAIN

Value in health, 2007, Vol.10 (6), p.A398-A399

2007

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(51)

Sprache

Englisch
(50)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Internal Medicine
(28)
Science & Technology
(7)
Life Sciences & Biomedicine
(4)
Chemistry
(3)
Electrochemistry
(3)
Exact Sciences And Technology
(3)
General And Physical Chemistry
(3)
Medicine
(3)
Physical Sciences
(3)
Aged
(2)
Aged, 80 And Over
(2)
Electrodes: Preparations And Properties
(2)
Endocrinology & Metabolism
(2)
Female
(2)
Humans
(2)
Male
(2)
Medicine & Public Health
(2)
Middle Aged
(2)
Other Electrodes
(2)
Spain
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Patient preferences for osteoporosis in Spain: a discrete choice experiment

PCV72 Cost-Effectiveness of Rivaroxaban Versus Acenocumarol in the Stroke Prevention in Patients With Non-Valvular Atrial Fibrilation in the Spanish Setting

Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours

PCV109 Antithrombotic Therapy Prescription and Persistence in Patients With Atrial Fibrillation in France and Spain

PCN33 Cost Analysis: Treatment of Chemotherapy-Induced Anaemia with Erythropoiesis-Stimulating Agents (ESAs) in Spain

PMS68 - Biological Agents for Patients With Rheumatoid Arthritis Who Had Failed Treatment With Methotrexate In The Spanish Clinical Setting: A Cost-Effectiveness Analysis

Biological Agents for Patients With Rheumatoid Arthritis Who Had Failed Treatment With Methotrexate In The Spanish Clinical Setting: A Cost-Effectiveness Analysis

A simulation model to estimate the coronary heart disease risk in schizophrenic patients treated with second-generation-antipsychotic drugs: A Spanish perspective

PHP216 - HOW RESPONSIVE IS INDUSTRY TO VALUE BASED PROCUREMENT (VBP)?

PCV89 - A Comparison Of Two Low-Molecular-Weight Heparins (Lmwhs) In Terms Of Cost Per Patient

PCV63 - An Assesment Of Enoxaparine Benefit On Healthcare Budget In Spain

A Comparison Of Two Low-Molecular-Weight Heparins (Lmwhs) In Terms Of Cost Per Patient

An Assesment Of Enoxaparine Benefit On Healthcare Budget In Spain

P913Optimization of cardiac resynchronization therapy device selection guided by cardiac magnetic resonance imaging is cost-effective

PIN10 A BUDGET IMPACT MODEL TO ESTIMATE THE ECONOMIC IMPACT OF ITRACONAZOLE IN PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH NEUTROPENIA IN SPAIN

PIN64 A PROBABILISTIC COST-EFFECTIVENESS MODEL FOR PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH NEUTROPENIA IN SPAIN

Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain

PND41 - Cost-Effectiveness Analysis of Delayed-Release Dimethyl Fumarate for The Treatment of Relapsing Remitting Multiple Sclerosis In Spain

Posicionamiento de pegfilgrastim en las tablas clasificatorias de España según coste por años de vida ajustados por calidad (AVAC) y coste por años de vida ganados (AVG)

PG120 ASSESSING THE COST AND EFFECTIVENESS OF TERLIPRESSIN COMPARED WITH SOMATOSTATIN FOR THE TREATMENT OF BLEEDING OESOPHAGEAL VARICES IN SPAIN

PG15 A BUDGET IMPACT ANALYSIS FOR DETERMINING THE COSTS OF INCREASED PANTOPRAZOL IV PRESCRIPTION FOR THE MANAGEMENT OF PEPTIC ULCER IN SPAIN

PRS7 THE TREATMENT OF MODERATE TO SEVERE PERSISTENT ASTHMA IN SELECTED AUTONOMOUS COMMUNITIES IN SPAIN: AN ECOMIC MODELTO ESTIMATE BUDGET IMPACT CONSEQUENCES OF INTRODUCING BECLOMETHASONE/FORMOTEROL

PG16 THE MANAGEMENT OF GASTRO OESOPHAGEAL REFLUX DISEASE IN SPAIN: A BUDGET IMPACT ANALYSIS TO ESTIMATE COSTS DUETO A GREATER PANTOPRAZOL IV PENETRATION

PIN20 COST EFFECTIVENESS ANALYSIS OF BRIVUDINE COMPARED WITH ACICLOVIR FORTHETREATMENT OF HERPES ZOSTER IN SPAIN

PAA3 A BUDGET IMPACT MODEL FOR DETERMINING THE COSTS OF INTRODUCING A NEW EXTRAFINE COMBINATION (BECLOMETHASONE/FORMOTEROL) FOR THE TREATMENT OF MODERATE TO SEVERE PERSISTENT ASTHMA IN SPAIN

Suchergebnisse filtern